» Articles » PMID: 28402771

Autochthonous Japanese Encephalitis with Yellow Fever Coinfection in Africa

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2017 Apr 14
PMID 28402771
Citations 65
Authors
Affiliations
Soon will be listed here.
Citing Articles

[Fatal case of co-infection with yellow fever virus and SARS-CoV2 during the 2020 Covid-19 pandemic in French Guiana].

Thomas C, Pichard C, Rousset D, Demar M, Djossou F, Sanna A Med Trop Sante Int. 2025; 4(3).

PMID: 39931723 PMC: 11809067. DOI: 10.48327/mtsi.v4i3.2024.445.


Introduction of Vector-Borne Infections in Europe: Emerging and Re-Emerging Viral Pathogens with Potential Impact on One Health.

Logiudice J, Alberti M, Ciccarone A, Rossi B, Tiecco G, De Francesco M Pathogens. 2025; 14(1).

PMID: 39861024 PMC: 11768692. DOI: 10.3390/pathogens14010063.


Key virulence factors responsible for differences in pathogenicity between clinically proven live-attenuated Japanese encephalitis vaccine SA14-14-2 and its pre-attenuated highly virulent parent SA14.

Song B, Yun S, Goldhardt J, Kim J, Lee Y PLoS Pathog. 2025; 21(1):e1012844.

PMID: 39775684 PMC: 11741592. DOI: 10.1371/journal.ppat.1012844.


Mosquito populations originating from nonendemic areas have the potential to transmit recently emerging Japanese encephalitis virus genotype IV.

Faizah A, Kobayashi D, Azerigyik F, Matsumura R, Kai I, Maekawa Y Emerg Microbes Infect. 2024; 14(1):2438661.

PMID: 39655411 PMC: 11703388. DOI: 10.1080/22221751.2024.2438661.


Revisiting the risk of introduction of Japanese encephalitis virus (JEV) into the United States - An updated semi-quantitative risk assessment.

Dixon A, Oliveira A, Cohnstaedt L, Mitzel D, Mire C, Cernicchiaro N One Health. 2024; 19:100879.

PMID: 39253386 PMC: 11381889. DOI: 10.1016/j.onehlt.2024.100879.